4//SEC Filing
Kamen Robert 4
Accession 0001694187-20-000067
CIK 0001694187other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 9:07 PM ET
Size
8.2 KB
Accession
0001694187-20-000067
Insider Transaction Report
Form 4
Kamen Robert
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2020-05-06−18,500→ 0 totalExercise: $4.64→ Common Stock (18,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-05-06−14,000→ 0 totalExercise: $16.00→ Common Stock (14,000 underlying)
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 15, 2020, by and among the Issuer, BioNTech SE ("BioNTech"), and Endor Lights, Inc. a direct wholly owned subsidiary of BioNTech ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger") effective as of May 6, 2020 (the "Effective Time"), at the Effective Time these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the "Cash Merger Consideration").
Documents
Issuer
Neon Therapeutics, Inc.
CIK 0001694187
Entity typeother
Related Parties
1- filerCIK 0001693540
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 9:07 PM ET
- Size
- 8.2 KB